Company / Capital Returned to Shareholders
CME Group Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$3.9B
FY2025
5-year range
$2.2B / $3.9B
FY2021-FY2025
Trend
+9.7%
vs FY2024
Sector context
#24 of 365
Financials
What the data says
Among 365 Financials companies, CME Group is in the top 7% for capital returned to shareholders. Capital Returned to Shareholders has increased for 6 consecutive years, from $2.0B in FY2019 to $3.9B in FY2025.
Based on SEC 10-K filings.
$3.9B in FY2025 with a 5-year CAGR of +12.8%. Top quartile in the Financials sector.
Improved from $3.2B to $3.9B over the past 2 years.
Financials sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +14.3%
- 5-Year CAGR
- +12.8%
- 10-Year CAGR
- -
Sector benchmark
+251.4% above sector average
Key checks
Key Insights
- CME Group's capital returned to shareholders has grown for 6 consecutive years.
- 5-year CAGR of +12.8%, indicating consistent growth.
- In FY2025, capital returned to shareholders increased 9.7% year-over-year.
- Ranks #24 out of 365 companies in the Financials sector.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.9B | +9.7% |
| FY2024 | $3.6B | +10.8% |
| FY2023 | $3.2B | +22.9% |
| FY2022 | $2.6B | +20.3% |
| FY2021 | $2.2B | +1.8% |
| FY2020 | $2.1B | +7.8% |
| FY2019 | $2.0B | -7.3% |
| FY2018 | $2.1B | +7.8% |
| FY2017 | $2.0B | +11.5% |
| FY2016 | $1.8B | +33.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026